|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.000100 USD | 0.00% |
|
0.00% | -87.50% |
| 06-22 | Stemtech Corporation Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 05-29 | Stemtech Corporation Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
Vitamins and Nutritional Supplements | |||||||
Vitamins & Nutrition Products | 4.32M | 4.56M | 4.92M | 5.05M | 2.88M | ||
Total Assets | 5.72M | 4.27M | 3.68M | 3.78M | 3.15M | ||
Interest Expense | -8.33M | -4.1M | -4.89M | -1.58M | -1.45M | ||
Income Tax Expense | - | 95.62K | - | - | - | ||
CAPEX | - | - | - | - | - | ||
EBT | -7.11M | -8.54M | -5.43M | -3.77M | -4.05M | ||
Gross Profit | 3.3M | 3.4M | 3.92M | 3.73M | 2.31M | ||
D&A | 429K | 1.9M | 660K | 415K | 167K | ||
Operating Income | -3.21M | -5.02M | -4.22M | -2.39M | -2.71M | ||
Net Income | -7.08M | -8.54M | -5.43M | -3.77M | -4.05M |
Geographical Revenue Distribution History
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
Latin America | 1.67M | 2.5M | 3.07M | 2.67M | 1.53M | ||
Total Assets | 285K | 199K | 164K | 606K | 338K | ||
Operating Income | -834K | -45.49K | -237K | -320K | -1.04M | ||
Americas | 1.87M | 1.55M | 1.68M | 2.17M | 1.23M | ||
Total Assets | 5.21M | 3.99M | 3.45M | 3.12M | 2.79M | ||
Operating Income | -2.19M | -4.79M | -3.8M | -1.94M | -1.52M | ||
Asia | 787K | 511K | 180K | 215K | 117K | ||
Total Assets | 223K | 81.36K | 68.25K | 48.91K | 17.87K | ||
Operating Income | -189K | -188K | -189K | -123K | -146K |
- Stock Market
- Stocks
- STEK Stock
- Financials Stemtech Corporation
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
